CoreWeave's strong short-term liquidity and half its backlog set to convert by 2028 mean it won't go bust. At just 1.3x 2027 sales and probably 1x exit ARR, the only way the stock could be lower in 12 months is bankruptcy. x.com
Oguz Erkan
Investor, Founder of Capitalist Letters
CoreWeave looks increasingly undervalued given its sales outlook and low multiple. Consensus expects about $27 billion in sales next year without any uplift from per-MW pricing, yet it trades at 1.3x those sales and probably below 1x exit ARR. EBIT is projected to inflect after 2027 and free cash flow to improve in 2028. If it survives next year, it will be on its way to becoming a $500 billion company. x.com
CoreWeave's stock may already reflect much of its real financing risk amid extreme pessimism. Its unsecured bonds yield distressed rates and CDS spreads have surged, while Q2 net interest expense was $640M and 2026 capex guidance is $35–39B. Q2 revenue was $2.58B with about $104B of backlog, but whether that demand yields shareholder value after financing, depreciation and reinvestment remains uncertain; attractive financing is central to the case. x.com
CoreWeave could face a liquidity squeeze if customer prepayments funded parent needs or unrelated data centers while their own projects still need financing. Most of its >$7B in deferred revenue likely reflects prepayments. If credit tightens significantly, it could fail to complete projects, triggering delays or cancellations, refund demands and a cascading crisis. Signed projects still look economical, but its financing market has deteriorated meaningfully since June. x.com x.com x.com x.com
CoreWeave's risk is buildout speed: each new build needs capital before the last pays for itself. Its analysis shows $35.6B of loans lasting about nine months beyond customer contracts; $14.6B is due in 2031-32 as final contract cash arrives. IREN's Microsoft project loan matches its contract, but $6.3B of convertible bonds mature in 2031-33, mostly after contracted cash ends; low shares mean cash repayment. Slower AI demand growth could let both earn back projects before funding more. x.com
CoreWeave's pricing power is overlooked amid financing fears, making it potentially the most misunderstood AI stock right now. It had over $104B in Q2 backlog and signed $25B in net new commitments over six weeks. Short-term contracts approach $40M per MW annually versus about $7M on active capacity, but that rate cannot be applied fleetwide. A $4.2B convertible carried a 2.875% coupon despite near-15% unsecured bond yields; $35B debt, dilution and capacity-conversion risks remain. x.com
CoreWeave's 3.2x 2027 revenue multiple makes it one of the most attractive stocks in the market. x.com
CoreWeave looks like a poor long because its debt now exceeds its market capitalization. x.com
CoreWeave can deliver its return within months, once the market starts valuing the business beyond the next five years. Its signed $125 billion backlog will flow through over that period, and while debt will exceed $60 billion, that problem is widely known and already priced in. The market gives the company no credit beyond five years, so a shift in narrative toward longer-term thinking is what drives the gain. The approach is not perfect but is highly repeatable. x.com
CoreWeave's falling credit-risk spread and record-volume lower low point to possible capitulation after severe news. Its five-year CDS has fallen nearly 500 basis points from a 1,500-basis-point high; over the past two weeks it faced the worst news short of bankruptcy, including a CDS scare and Elon Musk spreading fear about neoclouds. This could be the bottom if the stock reclaims its July 29 level. x.com
CoreWeave's growing revenue and large backlog have not translated into positive fundamentals. Its trailing free cash flow has fallen to -$13.65 billion, net income to -$1.93 billion and EPS to -$3.66; the stock may still work out, but the uncertainty warrants caution. x.com
CoreWeave need not borrow at the 15.6% yield on its existing bonds or accept new contracts that lose money. Chamath's debt warning extrapolates that market yield to future financing, while CoreWeave can decline contracts whose rates do not work; its debt table shows varied effective rates, mostly below 15%. x.com